2019 RSS Annual Scientific Meeting: SITC Session

When:  Mar 22, 2019 from 7:00 AM to 9:00 AM (PT)
Presented by the Radiosurgery Society, in collaboration with the Society for Immunotherapy of Cancer

The Radiosurgery Society Annual Scientific Meeting is a collaborative multi-disciplinary gathering, bringing together world-class healthcare professionals who are passionate about the ongoing advancement of Stereotactic Radiosurgery/Stereotactic Body Radiotherapy (SRS/SBRT) and advancing therapies for patient care.  The Annual Scientific Meeting takes place from March 21-23, 2019.

As part of the scientific program, a joint session hosted by the RSS in collaboration with SITC on Current and Future Approaches to Combining Immunotherapy & Radiosurgery.  During this session, invited expert speakers will discuss the biology, physics and clinical roles of combination radiosurgery and immunotherapy for the treatment of cancer.  Current and future clinical trials will be discussed in the context of combined radiosurgery and immunotherapy.


Current and Future Approaches to Combining Immunotherapy & Radiosurgery

Session Chairs
Mansoor M. Ahmed, PhD – National Cancer Institute/National Institutes of Health
Marka Crittenden, MD, PhD* – Earle A. Chiles Research Institute, Providence Cancer Center

7:00 – 9:00 a.m.

Opening Remarks
Mansoor M. Ahmed, PhD – National Cancer Institute/National Institutes of Health

Cancer Immunology/Immunotherapy: A Primer for Radiation Oncologists & Medical Physicists
Alice O. Kamphorst, PhD* – Icahn School of Medicine at Mount Sinai

Opportunities and Challenges of Combining SBRT and Immunotherapy
Stephen L. Shiao, MD, PhD* – Cedars-Sinai Medical Center and University of California, Los Angeles

Combining Interleukin-2 and SBRT for Melanoma
Marka R. Crittenden, MD, PhD* – Earle A. Chiles Research Institute, Providence Cancer Center

FLT3 Ligand and SBRT for Lung Cancer
Chandan Guha, MBBS, PhDMontefiore Medical Center/Albert Einstein College of Medicine

Combination Immunotherapy and SBRT for Head & Neck Cancer
Nadeem Riaz, MDMemorial Sloan Kettering Cancer Center

Closing Remarks
Marka R. Crittenden, MD, PhD* – Earle A. Chiles Research Institute, Providence Cancer Center


*Denotes SITC Member

For more information, or to register, please click here.
#InPersonEvent
#Collaboration
#CombinationTherapy
#Clinician
#RegisteredNurse
#Oncologist
#Industry
#2019

Location

Sheraton San Diego Hotel & Marina
1380 Harbor Island Drive
San Diego, CA 92101